Folic acid and Reblozyl drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Folic acid and Reblozyl. Common interactions include fatigue among males.
The phase IV clinical study analyzes what interactions people who take Folic acid and Reblozyl have. It is created by eHealthMe based on reports of 10 people who take Folic acid and Reblozyl from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10 people who take Folic acid and Reblozyl together, and have interactions are studied.
What is Folic acid?
Folic acid has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 124,951 Folic acid users for its effectiveness, alternative drugs and more.
What is Reblozyl?
Reblozyl has active ingredients of luspatercept-aamt. eHealthMe is studying from 556 Reblozyl users for its effectiveness, alternative drugs and more.
Number of Folic acid and Reblozyl reports submitted per year:

Common Folic Acid and Reblozyl drug interactions by gender *:
female:
n/a
male:
- Fatigue
- Hepatic cirrhosis
- Hypotension
- Memory impairment
- Oedema peripheral
- Pain
- Pneumonia
- Pyrexia
- Renal impairment
- Respiratory tract infection
Common Folic Acid and Reblozyl drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Ammonia increased
- Arthralgia
- Blood potassium decreased
- Death
- Fatigue
- Hypotension
- Memory impairment
- Pain
- Pyrexia
- Respiratory tract infection
60+:
- Pulmonary embolism
- Cardiac failure congestive
- Hypervolaemia
- Oedema peripheral
- Pneumonia
- Renal impairment
- Urinary retention
- Urinary tract infection
- White blood cell count increased
Common conditions people have *:
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 7 people, 70.00%
- Haemochromatosis (body to absorb more iron than usual from food): 3 people, 30.00%
- Anaemia (lack of blood): 3 people, 30.00%
* Approximation only. Some reports may have incomplete information.
Do you take Folic acid and Reblozyl?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Folic acid (124,951 reports)
- Reblozyl (556 reports)
Browse all drug interactions of Folic acid and Reblozyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Folic acid side effects:
- Fatigue (feeling of tiredness): 9,736 reports
- Pain: 9,552 reports
- Drug ineffective: 8,663 reports
- Joint pain: 7,930 reports
- Rashes (redness): 7,091 reports
- Breathing difficulty: 6,404 reports
- Fever: 6,222 reports
Browse all side effects of Folic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Folic acid interactions:
- Folic acid and Methotrexate: 54,751 reports
- Folic acid and Humira: 27,554 reports
- Folic acid and Prednisone: 27,491 reports
- Folic acid and Enbrel: 16,298 reports
- Folic acid and Aspirin: 13,209 reports
- Folic acid and Remicade: 11,490 reports
- Folic acid and Omeprazole: 10,916 reports
- Folic acid and Acetaminophen: 8,217 reports
- Folic acid and Lisinopril: 7,243 reports
- Folic acid and Furosemide: 6,459 reports
Browse all interactions between Folic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on folic acid and luspatercept-aamt (the active ingredients of Folic acid and Reblozyl, respectively), and Folic acid and Reblozyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Folic acid and Reblozyl.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Combivent and Decreased Interest - now
- Refludan and Convulsion - 2 seconds ago
- Pain Exacerbated and Decreased Interest - 2 seconds ago
- Fentanyl and Decreased Interest - 2 seconds ago
- Pain and Decreased Interest - 5 seconds ago
- Zoloft and Catapres drug interaction - 7 seconds ago
- Quit Smoking and Decreased Interest - 8 seconds ago
- Nexium and Decreased Interest - 9 seconds ago
- Zide and Decreased Interest - 9 seconds ago
- Multivitamin and Decreased Interest - 14 seconds ago